©The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Gastrointest Oncol. Sep 15, 2021; 13(9): 1210-1212
Published online Sep 15, 2021. doi: 10.4251/wjgo.v13.i9.1210
Published online Sep 15, 2021. doi: 10.4251/wjgo.v13.i9.1210
Use of liquid biopsies in gastrointestinal cancers
Hussein H Khachfe, Department of Gastrointestinal Surgical Oncology, University of Pittsburgh, Pittsburgh, PA 15232, United States
Author contributions: Khachfe HH performed the research, wrote, and revised the letter.
Conflict-of-interest statement: The author does not report any conflict of interest. The author did not receive any funding.
Corresponding author: Hussein H Khachfe, MD, Doctor, Research Fellow, Department of Gastrointestinal Surgical Oncology, University of Pittsburgh, 3550 Terrace St, Pittsburgh, PA 15232, United States. hhk15@mail.aub.edu
Received: May 8, 2021
Peer-review started: May 8, 2021
First decision: June 16, 2021
Revised: June 16, 2021
Accepted: August 9, 2021
Article in press: August 9, 2021
Published online: September 15, 2021
Processing time: 124 Days and 20.6 Hours
Peer-review started: May 8, 2021
First decision: June 16, 2021
Revised: June 16, 2021
Accepted: August 9, 2021
Article in press: August 9, 2021
Published online: September 15, 2021
Processing time: 124 Days and 20.6 Hours
Core Tip
Core Tip: Liquid biopsies are a novel method to help physicians in the early diagnosis and management of various cancer subtypes. Due to the east of performance, cost-effectiveness, and quick results associated with liquid biopsies, this technique will be integrated more into the treatment of aggressive cancer types such as cholangiocarcinoma and pancreatic cancers. More prospective clinical trials are needed to validate results on this tool.